Sophisticated and simple
Overview: A New frontline strategy for BRAF V600E–mutant mCRC Metastatic colorectal cancer (mCRC) with the BRAF V600E mutation has historically challenged clinicians due to its…

Bezuclastinib Makes a Major Leap in KIT Exon 17/18 Mutant GIST Recent PEAK Phase 3 results are positioning Bezuclinib as a potentially practice-changing therapy for…
